Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 322 clinical trials
featured
A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

docetaxel in patients with advanced non-squamous NSCLC who have previously experienced radiographic disease progression on or after treatment with platinum-based chemotherapy in combination with CIT.

nivolumab
experimental drug
cancer
advanced non-squamous non-small cell lung cancer
advanced lung cancer
  • 199 views
  • 07 Jan, 2021
  • 109 locations
featured
RTOG 1216: Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

RTOG 1216: Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer

  • 470 views
  • 08 Nov, 2020
  • 1 location
featured
  • 228 views
  • 08 Nov, 2020
  • 1 location
featured
Spectrum Neutropenia in Breast Cancer

Spectrum Neutropenia in Breast Cancer

  • 76 views
  • 08 Nov, 2020
  • 1 location
featured
Prostate Cancer

Prostate Cancer

  • 72 views
  • 08 Nov, 2020
  • 1 location
featured
A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Screening Step) Lung-MAP Study

A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Screening Step) Lung-MAP Study

cancer
lung carcinoma
lung cancer
  • 28 views
  • 23 Nov, 2020
  • 1 location
Adjuvant Trastuzumab Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast Cancer

chemotherapy agent (docetaxel) for a brief duration, and the patients allocated to the comparator group (Group B) will be treated with chemotherapy plus one anti-HER2 treatment (trastuzumab) for one year.

cish
trastuzumab
breast surgery
immunostimulant
adjuvant therapy
  • 7 views
  • 04 Nov, 2020
  • 1 location
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving

tumor cells
immunological adjuvant
docetaxel
prostatectomy
  • 35 views
  • 07 Nov, 2020
  • 5 locations
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel Adriamycin Cyclophosphamide) Chemotherapy

This is an investigation of the safety and efficacy of Maxy-G34 in breast cancer patients treated with TAC chemotherapy. Maxy-G34 will be given as a single injection during each cycle of chemotherapy, for a planned total of six chemotherapy cycles.

adriamycin
immunostimulant
anthracyclines
cyclophosphamide
docetaxel
  • 68 views
  • 07 Nov, 2020
  • 1 location
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer

To compare disease-free survival (DFS) rate of adjuvant chemotherapy epirubicin-cyclophosphamide followed by weekly paclitaxel or docetaxel (EC-T), or weekly paclitaxel or docetaxel-carboplatin

carboplatin
progesterone receptor
immunostimulant
estrogen
epirubicin
  • 90 views
  • 16 Apr, 2020
  • 27 locations